Literature DB >> 8178550

Biodegradable microspheres as controlled-release tetanus toxoid delivery systems.

M J Alonso1, R K Gupta, C Min, G R Siber, R Langer.   

Abstract

Purified tetanus toxoid, a high-molecular-weight protein, was entrapped within poly(L-lactic acid) (PLA) and poly(D,L-lactic/glycolic acid) (PLGA) microspheres prepared by either a solvent extraction or a solvent evaporation method carried out in a multiple emulsion system (water-in-oil-in-water). The physical integrity and antigenicity of the protein treated under different processing conditions were investigated. A reduction of antigenicity that was related to the percentage of aggregated protein was noticed under some experimental conditions. This partial loss of antigenicity was associated with the lyophilization process and affected by the nature of the organic solvent. All types of microspheres prepared with different molecular weight PLA and PLGA displayed a high protein-loading efficiency (> 80%) but their size was strongly influenced by polymer molecular weight (3000 versus 100,000). Protein release pattern was influenced by both polymer molecular weight and composition (PLA versus PLGA). A constant release pattern after an induction period of 10 days was observed for microspheres composed of high-molecular-weight polymers (PLA and PLGA). The release rate was lower from PLA microspheres than from PLGA microspheres. In contrast, a continuously increasing release rate preceded by a burst was observed for low-molecular-weight (3000) PLGA microspheres. Microencapsulated tetanus toxoid was significantly more immunogenic in mice than fluid toxoid as determined by IgG anti-tetanus antibody levels and neutralizing antibodies. However, the magnitude and duration of the antibody response did not differ significantly from a similar dose of aluminium phosphate-adsorbed toxoid. We conclude that microencapsulated tetanus toxoid shows significant adjuvant activity.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8178550     DOI: 10.1016/0264-410x(94)90092-2

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  45 in total

Review 1.  Protein instability in poly(lactic-co-glycolic acid) microparticles.

Authors:  M van de Weert; W E Hennink; W Jiskoot
Journal:  Pharm Res       Date:  2000-10       Impact factor: 4.200

2.  Solvent exchange method: a novel microencapsulation technique using dual microdispensers.

Authors:  Yoon Yeo; Alvin U Chen; Osman A Basaran; Kinam Park
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

3.  The use of cyclophosphamide as an enhancer of the vaccine against foot-and-mouth disease.

Authors:  E L Portiansky; P H González; R P Laguens
Journal:  Experientia       Date:  1996-06-15

4.  Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives.

Authors:  P Johansen; Y Men; R Audran; G Corradin; H P Merkle; B Gander
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

5.  Aptamer-conjugated polymeric nanoparticles for targeted cancer therapy.

Authors:  Athulya Aravind; Yasuhiko Yoshida; Toru Maekawa; D Sakthi Kumar
Journal:  Drug Deliv Transl Res       Date:  2012-12       Impact factor: 4.617

6.  New age adjuvants and delivery systems for subunit vaccines.

Authors:  S Kurella; M Manocha; L Sabhnani; B Thomas; D N Rao
Journal:  Indian J Clin Biochem       Date:  2000-08

Review 7.  Delivery of small molecules for bone regenerative engineering: preclinical studies and potential clinical applications.

Authors:  Cato T Laurencin; Keshia M Ashe; Nicole Henry; Ho Man Kan; Kevin W-H Lo
Journal:  Drug Discov Today       Date:  2014-02-06       Impact factor: 7.851

8.  Antiangiogenic therapy and mechanisms of tumor resistance in malignant glioma.

Authors:  Ruman Rahman; Stuart Smith; Cheryl Rahman; Richard Grundy
Journal:  J Oncol       Date:  2010-04-11       Impact factor: 4.375

9.  In vivo Evaluation of Single Dose Tetanus Toxoid Vaccine Formulation with Chitosan Microspheres.

Authors:  R Manivannan; S A Dhanaraj; Y Udaya Bhaskara Rao; A Balasubramaniam; N L Gowrishankar; N Jawahar; S Jubie
Journal:  Indian J Pharm Sci       Date:  2008-01       Impact factor: 0.975

10.  Enhanced immunogenicity of microencapsulated tetanus toxoid with stabilizing agents.

Authors:  R Audran; Y Men; P Johansen; B Gander; G Corradin
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.